|
C6ORF115 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.106210E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.142000E-01 |
| Normal-vs-Stage2 |
7.277000E-01 |
| Normal-vs-Stage3 |
2.378500E-02 |
| Normal-vs-Stage4 |
3.499000E-01 |
| Stage1-vs-Stage2 |
5.392600E-01 |
| Stage1-vs-Stage3 |
1.052200E-01 |
| Stage1-vs-Stage4 |
9.154400E-01 |
| Stage2-vs-Stage3 |
1.178000E-01 |
| Stage2-vs-Stage4 |
5.791200E-01 |
| Stage3-vs-Stage4 |
3.416000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.526100E-02 |
| Normal-vs-AfricanAmerican |
9.098800E-01 |
| Normal-vs-Asian |
6.745000E-01 |
| Caucasian-vs-AfricanAmerican |
3.612200E-01 |
| Caucasian-vs-Asian |
1.640320E-02 |
| AfricanAmerican-vs-Asian |
7.194000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.873400E-01 |
| Normal-vs-Female |
7.978200E-02 |
| Male-vs-Female |
3.953800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.020600E-01 |
| Normal-vs-Age(41-60Yrs) |
3.864800E-01 |
| Normal-vs-Age(61-80Yrs) |
1.504600E-01 |
| Normal-vs-Age(81-100Yrs) |
2.804400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.025200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.696600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.114000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.050000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.763400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.264200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.180020E-04 |
| Classical-VS-Follicular |
8.062000E-02 |
| Classical-VS-Other |
5.641400E-01 |
| Classical-VS-Normal |
1.437600E-01 |
| Tall-VS-Follicular |
1.042600E-04 |
| Tall-VS-Other |
3.716000E-02 |
| Tall-VS-Normal |
1.967770E-04 |
| Follicular-VS-Other |
7.581800E-01 |
| Follicular-VS-Normal |
9.885200E-01 |
| Other-VS-Normal |
8.213200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.671000E-01 |
| Normal-vs-N1 |
8.236800E-01 |
| N0-vs-N1 |
8.145800E-01 |
|
|
